MFine raises USD 48 mn funding from Moore Strategic Ventures, BEENEXT and others
The series C round also saw participation from existing investors, Stellaris Venture Partners, SBI Group Japan, SBI Ven Capital Singapore, Heritas Capital, Prime Venture Partners, Y'S Investment Pte Ltd and Alteria Capital, a statement said.
Digital health startup MFine on Wednesday said it has raised USD 48 million (about Rs 356.1 crore) in funding, co-led by Moore Strategic Ventures and BEENEXT.
The series C round also saw participation from existing investors, Stellaris Venture Partners, SBI Group Japan, SBI Ven Capital Singapore, Heritas Capital, Prime Venture Partners, Y'S Investment Pte Ltd and Alteria Capital, a statement said.
The new round of funding will help MFine invest in expanding its hospital, diagnostics and e-pharmacy network across the country and building tech-driven care delivery products for both acute and chronic conditions patients, it added.
MFine was founded in December 2017 by Ashutosh Lawania and Prasad Kompalli, who were later joined by Ajit Narayanan and Arjun Choudhary.
To date it has raised about USD 75 million in equity and debt.
Since its inception, over three million users have used MFine services with the platform clocking over three lakh monthly transactions that include doctor consultations, diagnostic tests, e-pharmacy and in-patient procedures.
In October 2018, MFine added another layer to its virtual doctor consultations by integrating with laboratory and diagnostic services and currently, it provides its users access to more than 700 diagnostic centres across 400 cities in India.
Over one lakh users use MFine for booking diagnostic tests every month, the statement said.
MFine has more than 6,000 doctors across 35 specialties on its platform and serves users in more than 1,000 towns across India.
See Zee Business Live TV Streaming Below:
The company said it is growing at 15 per cent month-on-month, amidst exponential adoption of telemedicine and digital health in India since the onset of the COVID-19 pandemic.
Earlier this year, MFine had launched an app-based SPO2 (blood oxygen saturation) monitoring tool to enable users to keep track of their oxygen saturation levels without needing an additional device. Since then, 2.5 lakh users have used the tool.
In the coming months, MFine will be extending the tool to measure heart rate and blood pressure, the statement said.
Over 500 corporates have partnered with MFine to enable services covering over five lakh employees. In the coming months, MFine will bring innovative financial solutions for users together with insurance partners, the statement said.
"In the healthcare sector the world has changed to a new normal and we are seeing a steep growth in the adoption of digital health in India too. We will continue to invest in deep tech to transform every smartphone into a health companion for consumers and a decision support assistant to all doctors," MFine CEO and co-founder Prasad Kompalli said.
He added that the company will also look to expand its network across India and make its services available widely.
Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.
RECOMMENDED STORIES
Rs 3,500 Monthly SIP for 35 years vs Rs 35,000 Monthly SIP for 16 Years: Which can give you higher corpus in long term? See calculations
SBI 444-day FD vs PNB 400-day FD: Here's what general and senior citizens will get in maturity on Rs 3.5 lakh and 7 lakh investments in special FDs?
SCSS vs FD: Which guaranteed return scheme will give you more quarterly income on Rs 20,00,000 investment?
Looking for short term investment ideas? Analysts suggest buying these 2 stocks for potential gain; check targets
Power of Compounding: How long it will take to build Rs 5 crore corpus with Rs 5,000, Rs 10,000 and Rs 15,000 monthly investments?
02:04 PM IST